Le Lézard
Classified in: Science and technology, Business
Subject: JVN

Falcon Investment Management Partners with FundFront to Launch Emerging Manager Platform


The partnership aims to equip Falcon's early-stage asset managers with scalable investment offerings and distribution capabilities.

LONDON, Oct. 11, 2023 /PRNewswire/ -- Today, FundFront, the leading technology provider for alternative investment platforms, announced that Falcon Investment Management Ltd., ("Falcon"), a UK-based alternative investment firm specializing in emerging manager strategies, has chosen FundFront's technology solutions to power its upcoming emerging manager platform.

Falcon's new platform, powered by FundFront's white-label technology, is poised to transform the way early-stage asset managers bring their investment ideas to fruition. It promises to eliminate traditional barriers, making it seamless for emerging managers to launch, manage, and distribute their strategies in a compliant manner.

Leveraging FundFront's securitization framework, Falcon enables asset managers to offer their investment opportunities to a global investor base via international clearing systems and exchanges. Investors can access these products directly from their custodian banks using an ISIN, meeting the demands of today's savvy investors.

Benny Menashe, CEO of Falcon, commented, "We understand the challenges faced by early-stage asset managers in today's landscape?operational complexities and capital raising hurdles. With this initiative, we're creating an ecosystem where managers' independence and unique narratives are celebrated, with FundFront's technology as the cornerstone of this transformative change."

Amin Naj, Founding Partner of FundFront, added, "Falcon's commitment to empowering the next generation of asset managers is inspiring. We're proud that our technology and solutions will play a pivotal role in supporting Falcon's innovative endeavors."

For asset managers seeking an efficient, compliant, and international route to market, Falcon's emerging manager platform offers an unparalleled opportunity. Partner asset managers gain solid operational support, expert risk management, and access to a platform that connects their products with a worldwide audience.

About FundFront

FundFront empowers financial institutions with alternative investment technology and solutions. Its platform serves as a vital link between asset managers and the wealth industry. By harnessing the power of technology, it brings access, liquidity, and transparency to the forefront, transforming the landscape of alternative investments for the benefit of all stakeholders.

For more information about FundFront, please visit https://fundfront.com

FundFront Ltd., is an Appointed Representative of Brooklands Fund Management Limited which is authorised and regulated by the Financial Conduct Authority with the firm reference number 757575 and the Securities and Exchange Commission with the registered number 286221. This material is not intended to provide any financial advice, and FundFront Ltd. recommends that investors seek specialist tax or financial advice before investing.

About Falcon Investment Management Ltd

Established in 2015 and headquartered in London, Falcon Investment Management stands as a leading alternative investment fund manager authorized and regulated by the Financial Conduct Authority (UK). Falcon's unique multi-manager platform is an ecosystem that supports and invests in early-stage and seasoned managers, aiming to bridge talent and opportunity gaps. With institutional-grade resources, Falcon grants its partner managers unparalleled access to capital, operational infrastructure, and global distribution opportunities.

Falcon Investment Management Ltd, is authorised and regulated by the Financial Conduct Authority (FCA). Registered in England and Wales with registered number 09277206 and FCA registered number FRN 673552.

For more information about Falcon, please visit: https://falconcapital.co.uk 

SOURCE FundFront


These press releases may also interest you

at 16:20
Verastem Oncology, , a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock,...

at 16:20
Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that Anil Kapur, Executive Vice President, Corporate Strategy and Chief Commercial Officer, will depart...

at 16:16
Total revenue increased 26% from the second quarter of 2023 to $628 millionDiluted earnings per share and adjusted earnings per share increased 29% and 28% from the second quarter of 2023 to $1.93 and $2.21, respectivelyTotal company combined loans...

at 16:15
Exelixis, Inc. announced today that its second quarter 2024 financial results will be released on Tuesday, August 6, 2024 after the markets close. At 5:00 p.m. ET / 2:00 p.m. PT, Exelixis management will host a conference call and webcast to discuss...

at 16:15
Nuvation Bio Inc. , a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced multiple updates for its taletrectinib program. Data from the global, pivotal Phase 2 TRUST-II study...

at 16:15
Nextracker announced today that Company leaders will present at the upcoming investor conference: KeyBanc Capital Markets 25th Annual Technology Leadership Forum Fireside Chat August 5, 2024 9:30 a.m. PT / 12:30 p.m. ET Live webcast will be...



News published on and distributed by: